Distinct Signatures of the Immune Responses in Low Risk Versus High Risk Neuroblastoma

Journal of Translational Medicine - United Kingdom
doi 10.1186/1479-5876-9-170
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Immune Responses to Low Back Pain Risk Factors

Work
MedicineEnvironmentalPublic HealthRehabilitationOccupational Health
2012English

Maintenance DFMO Increases Survival in High Risk Neuroblastoma

Scientific Reports
Multidisciplinary
2018English

Transcriptome Analysis Reveals Distinct Responses to Physiologic Versus Toxic Manganese Exposure in Human Neuroblastoma Cells

Frontiers in Genetics
GeneticsMolecular Medicine
2019English

Therapeutic Targeting of Non-Oncogene Dependencies in High-Risk Neuroblastoma

Clinical Cancer Research
Cancer ResearchOncology
2019English

Telomere Maintenance Is Pivotal for High-Risk Neuroblastoma

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2016English

Alternative NHEJ Pathway Components Are Therapeutic Targets in High-Risk Neuroblastoma

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2015English

Select BCL-2 Antagonism Restores Chemotherapy Sensitivity in High-Risk Neuroblastoma

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Meta-Mining of Copy Number Profiles of High-Risk Neuroblastoma Tumors

Scientific data
StatisticsProbabilityInformation SciencesUncertaintyLibraryInformation SystemsComputer Science ApplicationsEducation
2018English

Busulfan–melphalan in High-Risk Neuroblastoma: The 30-Year Experience of a Single Institution

Bone Marrow Transplantation
TransplantationHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy